$PACB stock has now risen 11% today, according to our price data from Polygon. There has been approximately $11,075,519 of trading volume.
Here is what we see in our data on $PACB (you can track the company live on Quiver's $PACB stock page):$PACB Insider Trading Activity
$PACB insiders have traded $PACB stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $PACB stock by insiders over the last 6 months:
- CHRISTIAN O HENRY (See Remarks) has made 0 purchases and 2 sales selling 272,406 shares for an estimated $505,692.
- OENE MARK VAN (See Remarks) has made 0 purchases and 2 sales selling 107,259 shares for an estimated $198,377.
- MICHELE FARMER (See Remarks) has made 0 purchases and 3 sales selling 32,517 shares for an estimated $55,110.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PACB Hedge Fund Activity
We have seen 85 institutional investors add shares of $PACB stock to their portfolio, and 114 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 14,861,287 shares (-87.1%) from their portfolio in Q1 2025, for an estimated $17,536,318
- BANK OF NEW YORK MELLON CORP removed 4,340,328 shares (-83.4%) from their portfolio in Q1 2025, for an estimated $5,121,587
- GOLDMAN SACHS GROUP INC removed 2,928,293 shares (-61.1%) from their portfolio in Q1 2025, for an estimated $3,455,385
- MORGAN STANLEY removed 2,279,826 shares (-40.3%) from their portfolio in Q1 2025, for an estimated $2,690,194
- WALLEYE CAPITAL LLC removed 1,943,046 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,292,794
- JACKSON SQUARE PARTNERS, LLC removed 1,788,905 shares (-35.0%) from their portfolio in Q1 2025, for an estimated $2,110,907
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,510,812 shares (-85.3%) from their portfolio in Q1 2025, for an estimated $1,782,758
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PACB Government Contracts
We have seen $2,055,825 of award payments to $PACB over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PACBIO REVIO REAGENTS: $274,176
- (8)102-817-900 REVIO REAGENT KIT, 24-PACK 103-071-500 ISO-SEQ EXPRESS 2.0 KIT 103-072-000 KINNEX FULL LENGT...: $209,120
- DEPT/DIR: BDRD/GENOMICS NMRC- FREDERICK8400 RESEARCH PLAZA, FORT DETRICK, MD 21702 PACIFIC BIOSCIENCES - V...: $173,000
- REVIO SPRQ REAGENT KIT: $137,088
- SHORT- READ NEXT GENERATION SEQUENCING PLATFORM (ONSO SYSTEM): $104,800
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$PACB Analyst Ratings
Wall Street analysts have issued reports on $PACB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 05/15/2025
- Canaccord Genuity issued a "Buy" rating on 04/10/2025
- Scotiabank issued a "Sector Outperform" rating on 03/25/2025
To track analyst ratings and price targets for $PACB, check out Quiver Quantitative's $PACB forecast page.
$PACB Price Targets
Multiple analysts have issued price targets for $PACB recently. We have seen 6 analysts offer price targets for $PACB in the last 6 months, with a median target of $1.65.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $1.5 on 06/25/2025
- David Westenberg from Piper Sandler set a target price of $1.25 on 05/15/2025
- Mason Carrico from Stephens & Co. set a target price of $1.8 on 05/15/2025
- Kyle Mikson from Canaccord Genuity set a target price of $3.0 on 04/10/2025
- Sung Ji Nam from Scotiabank set a target price of $2.0 on 03/25/2025
- Matthew Sykes from Goldman Sachs set a target price of $1.5 on 02/18/2025
You can track data on $PACB on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
